Merita KUCUKU works in National Agency for Medicines and Medical Devices. She finished the study of PhD in 2010 for quality control of vaccines. From year 2006 to 2012 she has been Head of National Regulatory Authority of Vaccines and Immunobiological Products of Albania, involved in regulatory, safety of vaccines issues. She participated as: - Member of Abortion WG for Safety of the Global Alignment of Immunization Safety in Pregnancy (GAIA Project) - Member of working group for Case Definition - Vasculitis, arranged from AIFA-Italy & Brighton Collaboration. Author of some publications in vaccines field, participant in different international meeting as presenter .
Pierre A. MORGON is CEO of MRGN Advisors and Regional Partner for Switzerland at Mérieux Développement. He is Chairman of the Board of Virometix, as well as Non-Executive Director to the Boards of Theradiag, of Eurocine Vaccines, and of Vaccitech. Pierre has over 30 years of experience in the global life science industry, especially with specialty care, vaccines and immunotherapy, at the helm of international operations, in C-level positions at global level in multinational corporations and as CEO of start-up companies. He is a lecturer in several MBA programs in world-class business schools and in life science conferences, and at the Mass Challenge biotechnology incubator in Switzerland. He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He is also an alumnus of INSEAD and IMD.
Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus” in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Research Professor. Dr. Stojanovich’s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings. She is in Editorial Boards (Editorial Boards LUPUS (LONDON). /Reviewer in the “CURRENT CONTENSTS” or “Science citation index”, like LUPUS REWIEWER DATABAS, Cellular and Molecular Neurobiology, The Journal of Vaccine <firstname.lastname@example.org , The Journal of Rheumatology, Allergologia et Immunopathologia and others. She is a member of number International Project, like of “the European Forum on Antiphospholipid Antibodies”, “Multicenter studies antiphospholipid antibodies, infections and autoimmune diseases”. She is a mentor/ Supervisor ships a numbers of post-doc students. She was in Invited Speaker for many lectures in Congresses and Symposia; organizer and Chairman of many Workshops, Seminars and Symposia; member of the Steering Committee of the “(EULAR) recommendations for vaccination in patients with auto-immune inflammatory rheumatic diseases (AIIRD)”, and EULAR Honorary Member; chairman in the International Congress “Antiphospholipid syndrome (Hughes syndrome) importance of multidisciplinary approaches- 30 years since definition”, 2013, “GRANT 2015” of the EUROPEAN STROKE CONFERENCE » for “excellent research in cerebrovascular diseases reviewed by the Scientific and programmer Committees”, and presented at the 24th Annual Meeting; Vienna, may, 2015. Member of ILLUMINATE steering committee: the phase 3 lupus ILLUMINATES clinical trials of Tabalumab/ Eli Lilly and Company., MD, PhD, FRCP, are willing to serve as a consultant to Lilly Research Laboratories, a division of Eli Lilly and Company (“Lilly”), in connection with the development of Tabalumab also known as LY2439821. Co- Chairman and the lector “LUPUS ACADEMY EASTERN EUROPEAN ROADSHOW of EULAR«: Belgrade, 18TH MARCH 2016, www.lupus-academy.org. Member of the American Association for the Advancement of Science (AAAS) from 2017. Professor Ljudmila Stojanovich’ Impact Point is 300.14, and number of citattions is 1,444.
Arwa Abdelhalim Mohammed has completed her MSc at the age of 25 from Ahfad University for Women, Khartoum, Sudan. She is the Doctor Advancement committee Coordinator in Sudan Medical Council and she was the organizer of Medical Professionalism Course that conducts by Sudan Medical Council. She has 4 publications. She is a lecturer in Nile College Faculty of pharmacy department of Biotechnology and she is one of the team of researchers at Africa city of Technology, Department of Biotechnology Khartoum, Sudan.
Anouar ABIDI has completed his PhD at the age of 32 years from Carthage University, Tunisia. He is the professor of High Institute of Health and Paramedical Sciences, Tunisia. He has many publications in International Journals.
A practicing physician in the field of healthcare in the state of Kerala in India for the last 29 years and very much interested in basic research. My interest is spread across the fever, inflammation and back pain,. I am a writer. I already printed and published nine books in these subjects. I wrote hundreds of articles in various magazines. I presented 9 research papers in Indian Science Congress 2008 to 2017.And 2 papers selected for the coming 2018 Indian science congress. I presented 2 papers in Kerala science congress 2014 and 2017. After scientific studies for a long time, we have developed a theory, which proves the temperature of fever is to increase blood circulation. We have developed 8000 affirmative cross checking questions. It can explain all queries related with fever and it considers the messages of the body and the facts of physics
Got the Young Scientist Award, Aufau International Award 2016, Organised by Chemical Sciences review and Letters Life time Member of “The Association of Pharmaceutical Teachers of India”. UK/LM-110. International Editorial Advisory Board member (Chemistry and Analytical Chemistry) at Cambridge Scholars Publishing Cambridge Scholars Publishing Lady Stephenson Library Welbeck Road Newcastle upon Tyne NE6 2PA United Kingdom
Uraiwan I. completed her Ph.D. from Montana State University, USA. Now she is an associate professor in Microbiology, Division of Medical technology, Faculty of Allied Health Sciences, Burapha University, Thailand. Her scientific fields mainly focus in molecular virology and now research interests expand to an innovative approaches in viral detection and vaccines. She was invited as a keynote speaker on the topic “Advance and innovations to detect enteric viruses in seafood” and a speaker on the topic “The emergence of uncommon genotypes of rotaviruses in Thailand” at the 7th International conference on Agriculture, Chemical, Biological and Environmental Sciences on 22-24 May 2017 at Kuala Lumpur, Malaysia. She enjoys to solve scientific problems and shares research knowledge with other scientists.
Kalita D J has completed his PhD from IVRI, Deemed University, in the year 2007. In the year 2012 he has completed his Post Doctoral Research in “Preparation of Marker Vaccine” from Institute for Animal Health, United Kingdom under most prestigious DBT=CREST Award from Govt. of India. He is also a Law graduate and rendering help to many common people at the hour of need. He has more than 80 numbers of publications in various national and international journals of repute. Dr. Kalita is serving as members of various reputed journals. Dr. Kalita is working as resource persons regularly on invitation at both regional and national level. He presented a more than 30 and 15 numbers of research and lead papers respectively in both India and abroad at National and International conferences. He is also act as OCM in several national and international conferences. Presently Professor Dr Kalita is working as PI in various externally funded project on Stem cell Therapy, Development of synthesize peptide Vaccine for various diseases including canine cancer etc.
Stem cell Therapy, Development of synthesize peptide Vaccine for various diseases including canine cancer etc.